We found that FSTL3 expression levels were correlated with TMB among multiple types of cancers, including BRCA, CHOL, LGG, LIHC, LUSC, PCPG, and THYM, but not CRC (Figure 11D, Table S8). This evidence concerns the gene FSTL3 and colorectal carcinoma.